Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A Patient”

486 trials

Showing 20 of 486 results

Not applicableApproved For MarketingNCT03154437
What this trial is testing

An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors

Who this might be right for
Hemophilia A
Genentech, Inc.
Not applicableUnknownNCT02581735
What this trial is testing

Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia

Who this might be right for
Haemophilia
Real Fundación Victoria Eugenia 40
Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Not applicableStudy completedNCT00244114
What this trial is testing

Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Not applicableStudy completedNCT04953000
What this trial is testing

Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

Who this might be right for
Hemophilia A
Takeda 94
Not applicableUnknownNCT02061033
What this trial is testing

Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease

Who this might be right for
Hemophilia AHemophilia BVon Willebrand's Disease
Karolinska University Hospital 180
Early research (Phase 1)Study completedNCT01562587
What this trial is testing

Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 18
Not applicableStudy completedNCT01318707
What this trial is testing

Biomarkers Serum Collection Methodology Pilot Study

Who this might be right for
Hemophilia A
Georgetown University 20
Large-scale testing (Phase 3)Study completedNCT01945593
What this trial is testing

BAX 855 Continuation

Who this might be right for
Hemophilia A
Baxalta now part of Shire 218
Large-scale testing (Phase 3)Study completedNCT01233258
What this trial is testing

A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
Bayer 80
Not applicableStudy completedNCT05104164
What this trial is testing

Self-myofascial Release in Hemophilic Ankle Arthropathy

Who this might be right for
Hemophilia
Investigación en Hemofilia y Fisioterapia 20
Post-approval studies (Phase 4)UnknownNCT04621916
What this trial is testing

Preventing Inhibitor Recurrence Indefinitely

Who this might be right for
Hemophilia AImmune Tolerance
Children's Hospital Los Angeles 52
Testing effectiveness (Phase 2)Study completedNCT00108758
What this trial is testing

Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 23
Large-scale testing (Phase 3)Study completedNCT04456387
What this trial is testing

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Who this might be right for
Hemophilia A
Zhengzhou Gensciences Inc 119
Not applicableUnknownNCT03914209
What this trial is testing

Extended Half-Life (EHL) Clotting Factor for Improving the Musculoskeletal Health of Patients With Hemophilia

Who this might be right for
Haemophilia
Investigación en Hemofilia y Fisioterapia 40
Large-scale testing (Phase 3)Study completedNCT02622321
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors

Who this might be right for
Hemophilia A
Hoffmann-La Roche 113
Not applicableUnknownNCT01856751
What this trial is testing

Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa

Who this might be right for
Haemophilia
Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy Krwotoczne Thrombus 80
Testing effectiveness (Phase 2)UnknownNCT04592692
What this trial is testing

A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip

Who this might be right for
Hemophilia A With Inhibitor
Ascension Healthcare Development Limited 20
Not applicableActive Not RecruitingNCT05643560
What this trial is testing

An Observational Study Called JOIHA to Learn More About How Well the Treatment With Jivi Works to Prevent Problems With Joints in Adults With Hemophilia A.

Who this might be right for
Hemophilia AProphylaxis of Bleeding
Bayer 33
Not applicableStudy completedNCT02439710
What this trial is testing

Patient Reported Outcomes Burdens and Experiences - Phase 2

Who this might be right for
Hemophilia
McMaster University 656
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation